L-FABP is useful renal biomarker originated from Japan. L-FABP enables early diagnosis of diabetic nephropathy, risk differentiation of renal dysfunction, monitoring of treatment effect of renal diseases and prediction of onset of acute kidney injury. L-FABP is CE certified and Japanese reimbursed product.